8/2/22 1:58 PM
14th Bioprocessing Summit, Boston
From August 15-18, 2022 the 14th Bioprocessing Summit will take place in Boston. The Bioprocessing...
read more
6/14/22 10:00 AM
27th ESACT Meeting, Lisbon
From 26-29 june, 2022, ESACT will be celebrating 46 years since the first conference. The program...
read more
5/10/22 11:15 AM
c-LEcta at BPI Europe, Vienna
17.05.22 - 19.05.22, Vienna (Austria) The BPI Europe 2022 scientific agenda covers today's latest...
read more
2/15/22 10:00 AM
c-LEcta announces that it has reached agreement to be acquired by Kerry Group
c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, has...
read more
12/16/21 9:15 AM
c-LEcta continues its growth in 2021 and sees itself excellently positioned for the future with the ENESYZ technology platform
c-LEcta continued its growth in 2021. The high expectations for the fiscal year have been fully met...
read more
11/11/21 8:30 AM
c-LEcta expands product range to include additional enzyme NuCLEANase
c-LEcta is launching a newly developed enzyme product. NuCLEANase® is a highly active endonuclease...
read more
10/14/21 11:00 AM
OFB Projektentwicklung realises biotechnology campus in Leipzig and thus creates new headquarters for c-LEcta
OFB is developing a biotechnology campus in Leipzig by the fourth quarter of 2024. The first...
read more
9/22/21 11:00 AM
Successful development of a screening method in Bacillus
The R&D enzyme development team at c-LEcta has succeeded in performing enzyme screenings on the...
read more
8/31/21 10:15 AM
Drug Master File for the use of the enzyme DENARASE® in the pharmaceutical industry accepted by the US FDA
c-LEcta has announced the submission of a Master File for its best-selling product DENARASE®. The...
read more
6/15/21 10:59 AM
c-LEcta exceeds EUR 10 million in revenue with significantly higher EBITDA
c-LEcta managed to successfully continue its growth in the fiscal year 2020 despite a challenging...
read more